Foyston, Gordon, & Payne Inc Medtronic PLC Transaction History

Foyston, Gordon, & Payne Inc

$392 Million
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$78.71 - $87.02 $73,908 - $81,711	-939 Reduced 0.5%	187,632 $14.8 Million
Q1 2024 May 07, 2024	SELL	$82.84 - $88.09 $352,484 - $374,822	-4,255 Reduced 2.21%	188,571 $16.4 Million
Q4 2023 Feb 07, 2024	BUY	$69.43 - $83.43 $1.44 Million - $1.73 Million	20,775 Added 12.07%	192,826 $15.9 Million
Q3 2023 Oct 26, 2023	SELL	$78.22 - $90.4 $1.07 Million - $1.23 Million	-13,638 Reduced 7.34%	172,051 $13.5 Million
Q2 2023 Aug 01, 2023	BUY	$79.47 - $91.38 $1.04 Million - $1.2 Million	13,097 Added 7.59%	185,689 $16.4 Million
Q1 2023 May 03, 2023	BUY	$76.72 - $87.58 $843,459 - $962,854	10,994 Added 6.8%	172,592 $13.9 Million
Q4 2022 Feb 09, 2023	BUY	$76.18 - $87.74 $1.83 Million - $2.1 Million	23,962 Added 17.41%	161,598 $12.6 Million
Q3 2022 Nov 04, 2022	BUY	$80.75 - $95.31 $3.19 Million - $3.76 Million	39,448 Added 40.18%	137,636 $11.1 Million
Q2 2022 Aug 11, 2022	SELL	$87.4 - $113.09 $4.06 Million - $5.26 Million	-46,510 Reduced 32.14%	98,188 $8.81 Million
Q1 2022 Apr 27, 2022	SELL	$100.58 - $112.38 $2.35 Million - $2.62 Million	-23,318 Reduced 13.88%	144,698 $16.1 Million
Q4 2021 Feb 11, 2022	SELL	$99.53 - $127.75 $1.54 Million - $1.97 Million	-15,449 Reduced 8.42%	168,016 $17.4 Million
Q3 2021 Nov 12, 2021	SELL	$122.75 - $135.17 $910,805 - $1 Million	-7,420 Reduced 3.89%	183,465 $23 Million
Q2 2021 Aug 06, 2021	SELL	$118.19 - $131.5 $2.27 Million - $2.53 Million	-19,233 Reduced 9.15%	190,885 $23.7 Million
Q1 2021 May 14, 2021	SELL	$111.18 - $119.74 $1.35 Million - $1.46 Million	-12,183 Reduced 5.48%	210,118 $24.8 Million
Q4 2020 Feb 12, 2021	SELL	$100.57 - $117.14 $1.15 Million - $1.34 Million	-11,443 Reduced 4.9%	222,301 $26 Million
Q3 2020 Nov 12, 2020	SELL	$90.13 - $108.78 $2.82 Million - $3.4 Million	-31,270 Reduced 11.8%	233,744 $24.3 Million
Q2 2020 Aug 14, 2020	SELL	$84.11 - $103.33 $3.72 Million - $4.57 Million	-44,211 Reduced 14.3%	265,014 $24.3 Million
Q1 2020 May 15, 2020	SELL	$72.92 - $121.3 $5.71 Million - $9.5 Million	-78,355 Reduced 20.22%	309,225 $27.9 Million
Q4 2019 Feb 14, 2020	SELL	$104.49 - $114.54 $571,037 - $625,961	-5,465 Reduced 1.39%	387,580 $44 Million
Q3 2019 Nov 14, 2019	SELL	$98.02 - $111.18 $2.62 Million - $2.97 Million	-26,714 Reduced 6.36%	393,045 $42.7 Million
Q2 2019 Aug 15, 2019	BUY	$84.15 - $99.38 $315,730 - $372,873	3,752 Added 0.9%	419,759 $40.9 Million
Q1 2019 May 14, 2019	BUY	$82.45 - $93.79 $224,181 - $255,015	2,719 Added 0.66%	416,007 $37.9 Million
Q4 2018 Feb 08, 2019	SELL	$85.8 - $99.49 $6.06 Million - $7.03 Million	-70,645 Reduced 14.6%	413,288 $37.6 Million
Q3 2018 Nov 02, 2018	SELL	$85.91 - $99.17 $1.22 Million - $1.41 Million	-14,237 Reduced 2.86%	483,933 $47.6 Million
Q2 2018 Aug 10, 2018	BUY	$77.48 - $87.83 $1.14 Million - $1.29 Million	14,674 Added 3.03%	498,170 $42.6 Million
Q1 2018 May 14, 2018	BUY	$76.55 - $87.26 $743,530 - $847,556	9,713 Added 2.05%	483,496 $38.8 Million
Q4 2017 Feb 14, 2018	SELL	$76.93 - $83.5 $6.92 Million - $7.51 Million	-89,937 Reduced 15.95%	473,783 $38.3 Million
Q3 2017 Nov 14, 2017	BUY	$77.71 - $84.6 $12.5 Million - $13.6 Million	160,884 Added 39.94%	563,720 $43.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	402,836	402,836 $35.8 Million

Others Institutions Holding MDT

# of Institutions

2,288

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

Vanguard Group Inc Valley Forge, PA

123M
Shares

$10 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

112M
Shares

$9.07 Billion
0.2% of portfolio
State Street Corp Boston, MA

60.7M
Shares

$4.92 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

32.6M
Shares

$2.64 Billion
0.63% of portfolio
Jpmorgan Chase & CO New York, NY

30M
Shares

$2.43 Billion
0.22% of portfolio

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foyston, Gordon, & Payne Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foyston, Gordon, & Payne Inc with notifications on news.

Account